SVT

(redirected from Superficial Vein Thrombosis)
AcronymDefinition
SVTSveriges Television
SVTSciences de la Vie et de la Terre
SVTSupraventricular Tachycardia
SVTSolid Vinyl Tile (flooring)
SVTSilicon Vertex Tracker (RHIC)
SVTSplenic Vein Thrombosis (pancreas)
SVTSynthetic Vision Technology (aviation; various companies)
SVTSuperbatch Vector Table
SVTSpecial Vehicle Team
SVTSequential Variable Valve Timing
SVTSilicon Vertex Tracker
SVTSturtevant (Amtrak station code; Sturtevant, WI)
SVTSalvage Vanguard Theater (Austin, TX)
SVTSpecial Vehicles Team (Ford)
SVTSvensk Tidskrift (Swedish political magazine)
SVTSuperficial Vein Thrombosis (disease)
SVTSamozaryadnaya Vintovka Tokareva (Tokarev semi-automatic rifle)
SVTScanner Validation Tool (Kodak)
SVTSurvivors of Violence and Torture (various organizations)
SVTStolen Vehicle Tracking
SVTSequential Valve Timing (Mazda)
SVTSoqosoqo ni Vakavulewa ni Taukei (Fijian political party)
SVTSpecimen Validity Test
SVTSociety of Vascular Technology
SVTSuper Valve Technology (Ampeg)
SVTSinus Venous Thrombosis (medical condition)
SVTSecure Vantage Technologies (Houston, TX)
SVTSystem Verification Testing
SVTSystem Validation Test
SVTSimi Valley Transit
SVTSpecialistes en Valeur du Tresor (18 primary dealers of French government bonds)
SVTSentence Verification Technique (reading comprehension assessment)
SVTScience Validation Team
SVTScreen Virtualization Technology
SVTSingle-Visit Training
SVTSoftware Verification Test
SVTSubscriber Voice Terminal
SVTSimulation Verification Tool
SVTSystemic Venous Thrombosis
SVTSite Verification Team
SVTSchedule Variance in Time
SVTSinus Ventricular Tachycardia (heart disorder)
SVTSingle Version of the Truth
SVTScience Verification Test (space research)
SVTSecure Voice Terminal
SVTStress and Volume Testing
SVTSnoqualmie Valley Transportation (King County, WA)
References in periodicals archive ?
In total, 168 patients, including patients with acute superficial vein thrombosis (SVT) and deep vein thrombosis (DVT), elderly patients who could not stand up, and patients who did not cooperate to Valsalva's maneuver, were excluded from the study.
Both protein C and S deficiency are autosomal dominant genetic disorders, usually manifesting as venous thromboembolism with deep and superficial vein thrombosis, pulmonary embolism, or both.
On the contrary, a somewhat higher rate of distal vein thrombosis was observed in the group of older women, but this was not statistically significant, while the incidence of superficial vein thrombosis (SVT) was significantly higher among the older than among the younger women (p = 0.04; Table 1).
Association between superficial vein thrombosis and deep vein thrombosis of the lower extremities.
A 37-year-old male presented with superficial vein thrombosis of the right laser saphenous vein in February of 2005.
The aim of this study was to evaluate the occurrence of deep venous thrombosis (DVT) and superficial vein thrombosis (SVT) and its prophylaxis with an oral anti-edema and antithrombotic agent (Pycnogenol, Horphag, Research Management SA, Geneva, Switzerland) in long-haul flights, in subjects at moderate to high-risk of DVT and SVT.
Washington, Aug 18 (ANI): Results from a new study have revealed that patients with clinically diagnosed superficial vein thrombosis (SVT), a blood clot in the veins just beneath the skin that commonly resolves on its own without treatment, are at increased risk of developing venous thromboembolism (VTE), a dangerous, often life-threatening condition.
Investigators in the study, known as the Comparison of Arixtra in Lower Limb Superficial Vein Thrombosis with Placebo (CALISTO) trial, compared the efficacy and safety of the specific factor Xa inhibitor fondaparinux with placebo in reducing symptomatic venous thromboembolic complications or death from any cause.
Leon L, Giannoukas AD, Dodd D, et al: Clinical significance of superficial vein thrombosis.Eur J Vasc Endovasc Surg2005:10-7.
The decision was supported by the results of the CALISTO study (Comparison of Arixtra in lower LImb Superficial vein Thrombosis with placebO), the first study in SVT to show a clinical effect with an anticoagulant treatment versus placebo, the company said.
Physical examination often reveals distention of the collateral veins and a palpable cord if there is an associated superficial vein thrombosis. Patients presenting for the first time with a suspected DVT may have symptoms that could be caused by popliteal (Baker's) cyst, infective cellulitis, superficial thrombophlebitis, or lymphatic obstruction.
Full browser ?